IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.779
AS - Asia 4.957
EU - Europa 4.778
SA - Sud America 841
Continente sconosciuto - Info sul continente non disponibili 808
AF - Africa 81
OC - Oceania 5
Totale 20.249
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.489
SG - Singapore 1.993
CN - Cina 1.247
IT - Italia 943
IE - Irlanda 679
BR - Brasile 651
RU - Federazione Russa 590
VN - Vietnam 547
SE - Svezia 532
UA - Ucraina 522
GB - Regno Unito 397
DE - Germania 375
TR - Turchia 369
FR - Francia 257
IN - India 214
FI - Finlandia 191
CA - Canada 140
HK - Hong Kong 121
BD - Bangladesh 118
KR - Corea 94
AR - Argentina 82
NL - Olanda 48
MX - Messico 46
AT - Austria 44
ID - Indonesia 38
PL - Polonia 37
JP - Giappone 33
EC - Ecuador 28
IQ - Iraq 28
ES - Italia 26
CO - Colombia 24
LT - Lituania 23
PH - Filippine 23
PK - Pakistan 23
ZA - Sudafrica 23
BE - Belgio 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 17
RO - Romania 15
CR - Costa Rica 14
GT - Guatemala 14
EE - Estonia 13
HN - Honduras 13
KE - Kenya 13
CH - Svizzera 12
PY - Paraguay 12
JM - Giamaica 10
NP - Nepal 10
SV - El Salvador 10
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
MY - Malesia 9
TN - Tunisia 9
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
MA - Marocco 7
PE - Perù 7
PR - Porto Rico 7
UZ - Uzbekistan 7
BG - Bulgaria 6
CW - ???statistics.table.value.countryCode.CW??? 6
IL - Israele 6
NI - Nicaragua 6
AU - Australia 5
AZ - Azerbaigian 5
BB - Barbados 5
DK - Danimarca 5
DZ - Algeria 5
HR - Croazia 5
TW - Taiwan 5
AL - Albania 4
CI - Costa d'Avorio 4
EU - Europa 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BS - Bahamas 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 19.434
Salva come PNG Salva come JPEG
Città #
Singapore 1.474
San Jose 1.080
Chandler 780
Jacksonville 699
Dublin 662
Dallas 559
Ashburn 541
Princeton 319
Council Bluffs 303
Beijing 300
Southend 244
Nanjing 215
Santa Clara 202
Izmir 195
Los Angeles 174
Ho Chi Minh City 169
The Dalles 166
Altamura 141
Hanoi 135
Munich 126
New York 113
Chieti 111
Dearborn 109
Hong Kong 106
Wilmington 104
Cambridge 98
Buffalo 93
Ann Arbor 87
Tongling 82
Boardman 76
Columbus 76
São Paulo 70
Redondo Beach 69
Nanchang 65
Moscow 59
Pescara 58
Phoenix 58
Rome 56
North Bergen 53
Orem 48
Helsinki 46
Milan 46
Brooklyn 45
Nuremberg 38
Shenyang 37
Denver 36
Montreal 36
Seattle 35
Turku 34
Chicago 33
Pune 33
Toronto 33
Warsaw 33
Tokyo 32
Washington 32
Dong Ket 30
Frankfurt am Main 30
Atlanta 29
Tianjin 28
Chennai 27
Haiphong 27
Hebei 27
Houston 27
Hefei 26
Jiaxing 25
London 25
Rio de Janeiro 25
Woodbridge 25
Da Nang 24
Kunming 24
Brasília 22
Hangzhou 22
Mexico City 22
Changsha 21
League City 21
Manchester 20
Stockholm 20
Mount Pleasant 18
Brussels 17
Mumbai 17
San Francisco 17
Boston 16
Grevenbroich 16
Kimball 16
Norwalk 16
Curitiba 15
Salvador 15
Baghdad 14
Jinan 14
Johannesburg 14
Vienna 14
Augusta 13
Changchun 13
Espoo 13
Guatemala City 13
Jeddah 13
Hải Dương 12
Nairobi 12
Poplar 12
Brno 11
Totale 11.502
Salva come PNG Salva come JPEG
Nome #
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 197
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 194
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 190
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 189
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 186
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 184
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 184
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 181
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 180
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 176
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 176
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 175
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 172
Acute urinary retention due to HSV-1: a case report 163
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 163
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 160
Metabolic modifications in HIV-infected women 158
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 157
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 155
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 154
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 154
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 153
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 151
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 149
Canakinumab in a subgroup of patients with COVID-19 149
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 145
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 145
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 143
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 142
Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era 141
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 141
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 141
Antiretroviral therapy management and rationalisation of available resources 139
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 138
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 138
Relevance of plant lectins in human cell biology and immunology 138
Is the rate of virological failure to cART continuing to decline in recent calendar years? 136
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 135
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 135
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 135
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 134
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 134
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 133
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 132
Associations between immune depression and cardiovascular events in HIV infection. 132
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 131
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 131
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 131
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 131
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 129
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 129
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 128
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 128
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 128
Normal breathing releases SARS-CoV-2 into the air 128
Inguinal lymphadenopathy due to Bartonella henselae 127
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 127
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 127
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 125
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 125
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 124
IL-1beta induces alkaline phosphatase in human phagocytes 123
Proteinuria in an African HIV-infected patient: effects of telmisartan. 123
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals 123
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 122
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 121
High dose of erythropoietin in management of interferon/ribavirin induced anemia 120
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 120
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART 120
Periodontitis and cytokine patterns in HIV positive patients 119
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 119
Early detection of pleuro-pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature 118
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 118
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 117
First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 117
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 116
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 116
Approach to COVID-19 in older adults and indications for improving the outcomes 116
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 115
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 114
Hypertension in HIV: Management and Treatment 114
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 114
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 113
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 113
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study. 113
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 113
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 113
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 113
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. 112
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 111
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 111
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 111
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 111
Pidotimod and Immunological Activation in Individuals Infected with HIV 111
Evaluation of Cell Migration and Cytokines Expression Changes under the Radiofrequency Electromagnetic Field on Wound Healing In Vitro Model 111
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 110
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 110
Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected? 109
Circulating extracellular vesicles as new inflammation marker in hiv infection 109
Interleukin-31: a new cytokine involved in inflammation of the skin 109
Totale 13.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022711 0 0 0 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/20252.970 187 528 383 112 60 134 97 183 267 209 336 474
2025/20266.810 470 251 876 897 590 370 1.115 405 670 646 363 157
2026/20271.833 165 368 470 830 0 0 0 0 0 0 0 0
Totale 20.249